Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity: a Randomized Clinical Trial

NCT03650205 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT03650205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03650205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity: a Randomized Clinical Trial
Lead sponsor
University of Sao Paulo
Phase
Not applicable
Overall status
Unknown status
Start date
January 22, 2019
Completion date
December 1, 2021
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity, chemotherapy effect, heart failure, neoplasms, oncology